Reuters ·  May 15 09:04
Vanda Pharmaceuticals Shares up 2% Premarket After Its Motion Sickness Treatment Succeeds in a Late-Stage Confirmatory Study
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment